Skip to main content
. 2004 Jun;136(3):513–520. doi: 10.1111/j.1365-2249.2004.02485.x

Fig. 4.

Fig. 4

(a) Comparison TGF-β levels in BALF between HTLV-I positive DPB patients who developed ATL and patients who did not develop ATL. TGF-β levels were significantly higher in HTLV-I positive DPB patients who developed ATL than those who did not develop ATL (*P < 0·01). (b) Comparison of MAP kinase protein phosphorylations. The JNK phosphorylation level of HTLV-I positive DPB patients who developed ATL (lane 3) was higher than those who did not develop ATL (lane 2) and HTLV-I negative DPB patients (lane 1). Data show the representative data of three different patients in each group. (c) Results of densitometry analysis of P-JNK/JNK. The JNK phosphorylation level of HTLV-I positive DPB patients who developed ATL (lane 3) was significantly higher than those who did not develop ATL (lane 2) and HTLV-I negative DPB patients (lane 1) (*P < 0·01, **P < 0·001, Bonferroni/Dunn with one-way factorial anova). Data are shown with mean ± standard deviation, n = 3 in each group).